Key facts
- · Type: New offering first sale 2026-01-02 · Amount sold: $25K · Total offering: $7M · SEC filing
- · Type: New offering first sale 2023-12-15 · Amount sold: $25K · Total offering: $4M · SEC filing
- · Type: New offering first sale 2023-02-08 · Amount sold: $1.35M · Total offering: $8M · SEC filing
Is BioCytics, Inc. a real, registered company?
BioCytics, Inc. is a registered filer with the SEC (CIK 1971839) and has filed since 2023-03-31. 3 filings are on record, the latest on 2026-03-13.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Who runs BioCytics, Inc.?
BioCytics, Inc.'s filings name Jim Powderly, John Powderly, Don Jackson and 2 more as its officers, directors or promoters.
How much has BioCytics, Inc. raised?
Its new offerings report $1.41M sold across 3 offerings, as its own filings state.
Run the free check on BioCytics, Inc. →
HUNTERSVILLE, NORTH CAROLINA
Biotechnology
3
$1.41M
Every filing
| Filed | Type | Amount sold | Total offering | Records |
|---|---|---|---|---|
| 2026-03-13 | New offering first sale 2026-01-02 | $25K | $7M | details · SEC filing |
| 2023-12-28 | New offering first sale 2023-12-15 | $25K | $4M | SEC filing |
| 2023-03-31 | New offering first sale 2023-02-08 | $1.35M | $8M | SEC filing |
Watch BioCytics, Inc.
Get an email when BioCytics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with BioCytics, Inc.?
Who to contact
- John Powderly — Executive Officer, Director
- Jim Powderly — Executive Officer
- Round: Form D filed 2026-03-13
- Amount sold: $25K
- Industry: Biotechnology
- Based: HUNTERSVILLE, NORTH CAROLINA
People listed
- John Powderly — Executive Officer, Director
- Jim Powderly — Executive Officer
- Filing: Form D filed 2026-03-13
- Amount sold: $25K
- Industry group: Biotechnology
- Based: HUNTERSVILLE, NORTH CAROLINA
- Entity type: Corporation
We'll show it in your MentionFox inbox when BioCytics, Inc. raises, hires or launches. No email unless you switch it on.
Watch BioCytics, Inc. →Want the whole picture on BioCytics, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on BioCytics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on BioCytics, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
3 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.
Every figure here is read from BioCytics, Inc.'s own filings with the SEC. The people those filings name are on the team page.